Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026
Absci official news RSS · 行業原文收錄 · 來源發佈：Tue Jul 14 2026 20:05:30 GMT+0000 (Coordinated Universal Time) · 本站收錄：Thu Oct 08 2026 09:07:26 GMT+0000 (Coordinated Universal Time)
已保存的原文節選
VANCOUVER, Wash. and NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will report business updates and financial and operating results
以上為帶出處的原文節選，完整內容請閱讀原始鏈接。自動收錄與主題分類不等於事實核驗。